Recombinant BCG ΔureC hly+ Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses

Por Desel, Christiane, Dorhoi, Anca, Bandermann, Silke, Grode, Leander, Eisele, Bernd, Kaufmann, Stefan H. E.
Publicado em 2011

Nonclinical Development of BCG Replacement Vaccine Candidates

Por Velmurugan, Kamalakannan, Grode, Leander, Chang, Rosemary, Fitzpatrick, Megan, Laddy, Dominick, Hokey, David, Derrick, Steven, Morris, Sheldon, McCown, David, Kidd, Reginald, Gengenbacher, Martin, Eisele, Bernd, Kaufmann, Stefan H.E., Fulkerson, John, Brennan, Michael J.
Publicado no Vaccines (Basel) (2013)

Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa

Por Loxton, André G., Knaul, Julia K., Grode, Leander, Gutschmidt, Andrea, Meller, Christiane, Eisele, Bernd, Johnstone, Hilary, van der Spuy, Gian, Maertzdorf, Jeroen, Kaufmann, Stefan H. E., Hesseling, Anneke C., Walzl, Gerhard, Cotton, Mark F.
Publicado no Clin Vaccine Immunol (2017)